Jeff D. Allen
Friends of Cancer Research · 97 works · 2,534 citations · h-index 21
Top works
- Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
- Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
- Despite Criticism Of The FDA Review Process, New Cancer Drugs Reach Patients Sooner In The United States Than In Europe
- Breaking a Vicious Cycle
- An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer
- Homologous Recombination Deficiency: Concepts, Definitions, and Assays
- Reducing the toxicity of cancer therapy: recognizing needs, taking action
- Considerations for the successful co-development of targeted cancer therapies and companion diagnostics
- Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project
- Impact of breakthrough therapy designation on cancer drug development
- Developing Standards for Breakthrough Therapy Designation in Oncology
- Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study
- Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts
- International liquid biopsy standardization alliance white paper
- The Friends of Cancer Research Real‐World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies
- Use of Multiple Endpoints and Approval Paths Depicts a Decade of FDA Oncology Drug Approvals
- Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
- National Maintenance Cost for Precision Diagnostics Under the Verifying Accurate Leading-Edge In Vitro Clinical Test Development (VALID) Act of 2020
- Regulatory decision-making meets the real world
- Real‐world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot